The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 1,329,437 | 292,184 | SH | SOLE | 292,184 | 0 | 0 | ||
SNAP INC | CL A | 83304A106 | 4,157,314 | 245,559 | SH | SOLE | 0 | 0 | 245,559 | ||
ROKU INC | COM CL A | 77543R102 | 5,289,424 | 57,707 | SH | SOLE | 57,707 | 0 | 0 | ||
DRAFTKINGS INC | COM CL A | 26142V105 | 231,085,182 | 6,555,608 | SH | SOLE | 6,555,608 | 0 | 0 | ||
INTEGRAL AD SCIENCE HLDNG CO | COM | 45828L108 | 326,980,660 | 22,722,770 | SH | SOLE | 22,722,770 | 0 | 0 |